Safety Analysis of Chronic Intake of a β-alanine Supplement

Randomized Clinical Trial to Analyze the Safety of Chronic Intake of a β-alanine Supplement in Active Individuals

Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.

After recruitment, subjects will be randomized and assigned to one of the two arms of the study: beta-alanine group or control group (placebo).

Subjects must be active people, and will take a dose of 15 g per day of the product for 4 weeks.

Inclusion Criteria:

• Men between 18 and 40 years of age.
• Physically active people. They must train at least 3 sessions per week.
• Have been training continuously for at least one year.

Exclusion Criteria:

• Participant suffering from chronic illness.
• Serious or terminal illness.
• Suffering from a lasting injury that prevents him/her from training in the month prior to the intervention.
• Inability to understand the informed consent.
• Previous experience in the consumption of beta alanine.